ALVO
NASDAQStockAlvotech
$3.55-0.18 (-4.83%)
52-Week Range
$3.73
$11.66
Key Stats
Market Cap
1.1B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.18
Volume
971.0K
Avg Volume
734.7K
Performance
1M
-28.27%
3M
-33.03%
6M
-54.06%
YTD
-25.40%
1Y
-67.19%
3Y
-72.08%
5Y
-66.67%
Price Chart
ETF Exposure
ALVO is held by 15 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| GLCR | GlacierShares Nasdaq Iceland ETF | 3.61% |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 0.43% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.09% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.06% |
| IBB | iShares Biotechnology ETF | 0.04% |
| STXK | Strive Small-Cap ETF | 0.02% |
| VEXC | Vanguard Emerging Markets ex-China ETF | 0.01% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.01% |
| VWO | Vanguard FTSE Emerging Markets ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.00% |
| SCHE | Schwab Emerging Markets Equity ETF | 0.00% |
| VEU | Vanguard FTSE All-World ex-US ETF | 0.00% |
| VSGX | Vanguard ESG International Stock ETF | 0.00% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% |
| VT | Vanguard Total World Stock ETF | 0.00% |
About ALVO ETF Exposure
Alvotech (ALVO) is held by 15 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.1B, ALVO is a widely held institutional stock. The stock currently trades at $3.55. Investors can gain exposure to ALVO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALVO, sorted by portfolio weight.